Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease-Reference-Cited by-同舟云学术

Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease

Published:2020-07-15 Issue:7 Volume:3 Page:e2010372
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Koch Giacomo¹²,Motta Caterina¹,Bonnì Sonia¹,Pellicciari Maria Concetta¹,Picazio Silvia¹,Casula Elias Paolo¹,Maiella Michele¹,Di Lorenzo Francesco¹,Ponzo Viviana¹,Ferrari Clarissa³,Scaricamazza Eugenia⁴,Caltagirone Carlo¹,Martorana Alessandro¹⁴

Affiliation:

1. Department of Behavioral and Clinical Neurology, Santa Lucia Foundation Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy

2. Section of Human Physiology, University of Ferrara, Italy

3. Unit of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy

4. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2768248/koch_2020_oi_200415_1597249387.43643.pdf

Reference42 articles.

1. Is dopamine involved in Alzheimer’s disease?;Martorana;Front Aging Neurosci,2014

2. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein–infused rats.;Itoh;J Neurochem,1996

3. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson’s, Alzheimer’s with parkinsonism, and Alzheimer’s disease.;Joyce;Mov Disord,1997

4. Dopamine and dopamine receptors in Alzheimer’s disease: a systematic review and network meta-analysis.;Pan;Front Aging Neurosci,2019

5. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer’s disease brain.;Kumar;Brain Res,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Different Diagnostic Measures on Drug Class Association with Dementia Progression Risk: A Longitudinal Prospective Cohort Study;Journal of Alzheimer's Disease;2024-07-16

2. Dopaminergic deficits along the spectrum of Alzheimer’s Disease;2024-03-14

3. Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease;Molecular Psychiatry;2024-01-16

4. Targets, trials and tribulations in Alzheimer therapeutics;European Journal of Pharmacology;2024-01

5. Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease;Frontiers in Cellular Neuroscience;2023-11-13